|
|
|
|
 |
|
|
|
|
|
| |
| Duane Gubler, Sc.D. |
| |
 A
citizen of the USA, received his BS in entomology and
zoology (Utah State University, 1963), his MS in Parasitology
(University of Hawaii, 1965) and his ScD in Pathobiology
and Disease Ecology (The Johns Hopkins University School
of Hygiene and Public Health, 1969). From 1969 to 1971,
Dr. Gubler worked at the Calcutta School of Tropical Medicine,
Calcutta, India on Bancroftian filariasis, with support
from The Johns Hopkins University International Center
for Medical Research and Training. In 1971, he joined
the faculty of Tropical Medicine and Medical Microbiology,
University of Hawaii School of Medicine, where he began
his career on dengue, helping develop new diagnostic methods
and applying them to the resurgent epidemics of dengue
that began in the Pacific Islands at that time. In 1975,
he took leave of absence from the University and went
to Indonesia where he initiated the Virology Department
at the US Naval Medical Research Unit Number 2 in Jakarta.
During this time he developed a new virologic surveillance
system for dengue/dengue hemorrhagic fever and continued
to study epidemics in Indonesia. In 1978, Dr. Gubler resigned
from the University of Hawaii and after a short stay at
the University of Illinois, took a position with the Division
of Vector-Borne Viral Diseases, CDC, ultimately as Chief,
Dengue Branch, San Juan, Puerto Rico from 1981-1989. In
Puerto Rico, he pioneered the concept of epidemic dengue
prevention based on active, laboratory-based surveillance,
rapid emergency response mosquito control, education of
the medical community for improved case management of
DHF patients and community-based, integrated Aedes aegypti
control for sustainable prevention. This approach now
forms the basis for the WHO Global Strategy for Prevention
and Control of DHF. In 1989, Dr. Gubler became Director,
Division of Vector-Borne Infectious Diseases, CDC in Fort
Collins. He has directed the development of the National
Lyme disease surveillance, prevention and control program,
the national and international responses to an epidemic
of pneumonic plague in India in 1994, and to West Nile
virus introduction into the US, 1999 to the present. He
has directed the CDC efforts to develop a tetravalent
chimeric dengue vaccine using the Mahidol University PDK-53
backbone. Dr. Gubler serves as an advisor and consultant
to WHO and other international health agencies. He has
received numerous scientific and community service awards,
and has over 210 published articles on all aspects of
vector-borne diseases, with emphasis on dengue/dengue
hemorrhagic fever, including the recent book on this subject.
He is married and has two sons. |
|
|
|
|
|
|
|
|
|
|
|
